FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

By
Bob
-
0
250
The US FDA approved Arexvy, the first RSV vaccine approved for use in the United States. Arexvy is approved for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
[FDA]
Press Release